SCHEMBL21757567

SCHEMBL21757567

O=CNc1ccc(OCCCN2CCOCC2)cc1

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 7/20 0.63
▸ MAPK1 P28482 2/20 0.63
▸ ALDH1A1 P00352 1/20 0.63
▸ CYP1A2 P05177 1/20 0.63
▸ CHRM2 P08172 1/20 0.63
▸ CHRM1 P11229 1/20 0.63
▸ HTR2A P28223 1/20 0.63
▸ SCN1A P35498 1/20 0.63
▸ HTR2B P41595 1/20 0.63
▸ KCNH2 Q12809 1/20 0.63
▸ SCN2A Q99250 1/20 0.63
▸ SIGMAR1 Q99720 1/20 0.63
▸ SCN3A Q9NY46 1/20 0.63
▸ EPHX2 P34913 8/20 0.62
▸ USP2 O75604 1/20 0.62
▸ LMNA P02545 1/20 0.62
▸ HRH2 P25021 1/20 0.59
▸ HRH1 P35367 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21757629 0.96 HRH3 (0.58) HRH3MAPK1ALDH1A1CYP1A2CHRM2
SCHEMBL21757618 0.95 KDM4E (0.59) HRH3MAPK1ALDH1A1CYP1A2CHRM2
SCHEMBL21276708 0.94 HRH3 (0.59) HRH3MAPK1ALDH1A1CYP1A2CHRM2
SCHEMBL14368318 0.93 CA12 (0.58) HRH3MAPK1ALDH1A1CYP1A2CHRM2
SCHEMBL21757596 0.91 TSHR (0.66) HRH3MAPK1ALDH1A1CYP1A2CHRM2
SCHEMBL21276824 0.84 HRH3 (0.51) HRH3MAPK1ALDH1A1CYP1A2CHRM2
SCHEMBL21276814 0.84 EPHX2 (0.51) HRH3MAPK1ALDH1A1CYP1A2CHRM2
SCHEMBL21276719 0.84 HRH3 (0.48) HRH3MAPK1ALDH1A1CYP1A2CHRM2
SCHEMBL21757528 0.82 HRH3 (0.62) HRH3KCNH2LMNAHRH2
SCHEMBL4730254 0.82 HRH3 (0.68) HRH3MAPK1ALDH1A1CYP1A2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3215509-B1 SUBSTITUTED PYRROLO[1,2-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS LYSOSOMAL THERAPEUTICS INC (US) 2020-02-26 — — EP disclosed
Send feedback